Defensins (HAD-1/HBD-1) as novel immune biomarkers in chronic hepatitis C: Association with inflammatory and antiviral cytokines and ROC-based diagnostic accuracy.

Enad AT, Jassim AJ, Alwandawi TK, Abbas RK

Open source

DOI
10.55133/eji.330308
Published
2026 Jul
Container
The Egyptian journal of immunology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.55133/eji.330308,
  title = {Defensins (HAD-1/HBD-1) as novel immune biomarkers in chronic hepatitis C: Association with inflammatory and antiviral cytokines and ROC-based diagnostic accuracy.},
  author = {Enad AT and Jassim AJ and Alwandawi TK and Abbas RK},
  year = {2026},
  journal = {The Egyptian journal of immunology},
  doi = {10.55133/eji.330308},
  url = {https://doi.org/10.55133/eji.330308}
}

RIS

TY  - JOUR
TI  - Defensins (HAD-1/HBD-1) as novel immune biomarkers in chronic hepatitis C: Association with inflammatory and antiviral cytokines and ROC-based diagnostic accuracy.
AU  - Enad AT
AU  - Jassim AJ
AU  - Alwandawi TK
AU  - Abbas RK
PY  - 2026
JO  - The Egyptian journal of immunology
DO  - 10.55133/eji.330308
UR  - https://doi.org/10.55133/eji.330308
ER  - 

APA

AT, E., AJ, J., TK, A., & RK, A. (2026). Defensins (HAD-1/HBD-1) as novel immune biomarkers in chronic hepatitis C: Association with inflammatory and antiviral cytokines and ROC-based diagnostic accuracy.. The Egyptian journal of immunology. https://doi.org/10.55133/eji.330308

Source records